Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-γ inducibility in non-small cell lung carcinoma cells: Lack of surface class II expression associated with a specific defect in HLA-DRA induction

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2495-2502

  Lu, Yanmei ^a   Boss, Jeremy M ^b   Hu, Shi Xue ^c   Xu, Hong Ji ^c   Blanck, George ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 2; MESSENGER RNA; RETINOBLASTOMA PROTEIN;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL GROWTH; IMMUNE RESPONSE; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LUNG NEOPLASMS; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029930050     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ting, J. P. 1993. Current concepts in DRA gene regulation. Immunol. Res. 12:65.
2. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259.
3. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J. J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
4. Fling, S. P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368:554.
5. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
6. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763.
7. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106.
8. Riley, J. L., S- D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both X-box region and the class II transactivator CIITA. Immunity 2:533.
9. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
10. Silvennoinen, O., J. N. Ihle, J. Schlessinger, and D. E. Levy. 1993. Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature 366:583.
11. Watling, D., D. Guschin, M. Muller, O. Silvennoinen, B. A. Witthuhn, F. W. Quelle, N. C. Rogers, C. Schindler, G. R. Stark, J. N. Ihle, and I. M. Kerr. 1993. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-γ signal transduction pathway (see comments). Nature 366:166.
12. Muller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J. E. Darnell, Jr., G. R. Stark, and I. M. Kerr. 1993. Complementation of a mutant cell line: central role of the 91-kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:4221.
13. Muller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harpur, G. Barbieri, B. A. Witthuhn, C. Schindler, S. Pellegrini, A. F. Wilks, J. N. Ihle, G. R. Stark, and I. M. Kerr. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction (see comments). Nature 366:129.
14. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
15. Lu, Y., G. D. Ussery, M. M. Muncaster, B. L. Gallie, and G. Blanck. 1994. Evidence for retinoblastoma protein (RB)-dependent and -independent IFN-gamma responses: RB coordinately rescues IFN-γ induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene 9:1015.
16. Helin, K., and E. Harlow. 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3:43.
17. Kim, S. J., S. Wagner, F. Liu, M. A. O'Reilly, P. D. Robbins, and M. R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-β 2 gene through transcription factor ATF-2. Nature 358:331.
18. Singh, P., J. Coe, and W. Hong. 1995. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374: 562.
19. Tschickardt, M. E., Y. Lu, M. Jacim, G. D. Ussery, V. Steimle, B. Mach, and G. Blanck. 1995. RB and a novel E2F binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class II transactivator CIITA in class n non-inducible RB-defective tumor lines. Int. J. Cancer 62:461.
20. Kratzke, R. A., E. Shimizu, J. Geradts, J. L. Gerster, S. Segal, G. A. Otterson, and F. J. Kaye. 1993. RB-mediated tumor suppression of a lung cancer cell line is abrogated by an extract enriched in extracellular matrix. Cell Growth Differ. 4:629.
21. Muncaster, M. M., B. L. Cohen, R. A. Phillips, and B. L. Gallic. 1992. Failure of RB1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res. 52:654.
22. Reimold, A. M., C. J. Kara, J. W. Rooney, and L. H. Glimcher. 1993. Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements. J. Immunol. 151:4173.
23. Woolfrey, A. E., L. C. Andersen, L. Shewey, J. Chung, and G. T. Nepom. 1993. Analysis of differential HLA-DQB expression in autologous B cell lines. J. Leukocyte Biol. 53:697.
24. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1995. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
25. Blanck, G., M. Lok, K. Kok, E. Downie, J. H. Korn, and J. L. Strominger. 1990. γ-Interferon induction of HLA class II mRNAs in dermal fibroblasts studied by RNAse protection analysis. Hum. Immunol. 29:150.
26. Long, E. O., T. LaVaute, V. Pinet, and D. Jaraquemada. 1994. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide. J. Immunol. 153:1487.
27. Lu, Y., G. D. Ussery, M. Jacim, M. Tschickardt, J. M. Boss, and G. Blanck. 1994. Retinoblastoma protein regulation of surface CD74 (invariant chain) expression in breast carcinoma cells. Mol. Immunol. 31:1365.
28. Valera, A., J. C. Perales, M. Hatzoglou, and F. Bosch. 1994. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Therapy 5:449.
29. Hadfield, C., B. E. Jordan, R. C. Mount, G. H. Pretorius, and E. Burak. 1990. G418-resistance as a dominant marker and reporter for gene expression in Saccharomyces cerevisiae. Curr. Genet. 18:303.
30. Atsumi, T., K. Hosoi, and T. Ueha. 1994. Involvement of high-affinity binding site for egf receptor in formation of rounding in a-431 epidermoid carcinoma cells. Horm. Metab. Res. 26:141.31.
31. Spies, T., R. Sorrentino, J. M. Boss, K. Okada, and J. L. Strominger. 1985. Structural organization of the DR subregion of the human major histocompatibility complex. Proc. Natl. Acad. Sci. USA 82:5165.
32. Berry, D. E., Y. Lu, P. G. Fallon, C. O'Connell, S. Hu, H. Xu, and G. Blanck. Retinoblastoma protein inhibits IFN-γ induced apoptosis. Oncogene. In press.
33. Baskar, S., V. Azarenko, E. Garcia Marshall, E. Hughes, and S. Ostrand-Rosenberg. 1994. MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice. Cell. Immunol. 155:123.
34. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J. Exp. Med. 181: 619.
35. Mao, C., D. Davies, I. M. Kerr, and G. R. Stark. 1993. Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon gamma. Proc. Natl. Acad. Sci. USA 90:2880.
36. Dive, C., C. D. Gregory, D. J. Phipps, D. L. Evans, A. E. Milner, and A. H. Wyllie. 1992. Analysis and discrimination of apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133:275.
37. Wyllie, A. H., J. F. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251.